Global /South Korea /Healthcare /Biotechnology /239610

HLscience Co., Ltd.

239610

• KRX: 239610 • Delayed

9,110KRW -0.8%

5.97 USD

As of 13 June 2026, HLscience Co., Ltd. has a market cap of $30.51M USD, ranking #34136 globally and #2104 in South Korea. It ranks #3080 in the Healthcare sector, and #592 in the Biotechnology industry.

Global Rank

34136

Country Rank

2104

Sector Rank

3080

Industry Rank

592

Key Stats

Market Cap

$30.51MUSD

46.4B KRW

Enterprise Value

$13.26MUSD

20.24B KRW

Revenue (TTM)

$10.98MUSD

16.71B KRW

EBITDA (TTM)

-$5.54MUSD

-8.46B KRW

Net Income (TTM)

-$7.84MUSD

-11.92B KRW

EBITDA Margin

-51%

Profit Margin

-71%

PS Ratio

2.8

PB Ratio

0.6

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Biotechnology

CEO

Hae-Yeon Yi open_in_new

Employees

Founded

2000

Website

hlscience.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.8%	12%	22%	16%	-0.9%	13%	-26%	-50%	-79%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	239610 (주)에이치엘사이언스 ISIN: KR7239610009 Shares Out.: Shares Outstanding: 5.093M¹ Shares Float: 1.521M² TV: TradingView: KRX: 239610 SA: Stock Analysis: KRX: 239610 YF: Yahoo Finance: 239610.KS GF: Google Finance: KRX: 239610 BA: Barron's: 239610 MS: Morningstar: XKRX: 239610	9,110 KRW	TV: TradingView: KRX: 239610 SA: Stock Analysis: KRX: 239610 YF: Yahoo Finance: 239610.KS GF: Google Finance: KRX: 239610 BA: Barron's: 239610 MS: Morningstar: XKRX: 239610

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About HLscience Co., Ltd.

HLscience Co., Ltd. manufactures and sells health functional foods in South Korea. The company offers organic barley grassjuice powder one day, queen’s pomegranate jin, Super LuzieA+ Astaxanthin, Dr. Superkhan, HL-JOINT 100 for Joint & Cartilage Premium, Dr. Green Propolis, morosil diet fit, skin master secret, enerlinger vitamin D, PS300 formulated by doctor, Skin Master P-estro, and Dr. Prebiotics Plus. It also provides CDMO, contract development organization and contract research organization, contract manufacturing organization, quality assurance system, and funding services. Its products are used for antioxidant/skin health/immune function, female menopausal health/skin moisturizing/UV care, liver health, cartilage and joint health/bone health, body fat reduction/energy metabolism, brain health/blood circulation improvement, and gut health applications. The company was founded in 2000 and is headquartered in Hwaseong-si, South Korea.

Similar Companies

Industry: Biotechnology (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 147K%	35.5	South Korea
Celltrion, Inc. KRX: 068270	$28.11B 42.76T KRW 92K%	43.8	South Korea
ALTEOGEN Inc. KRX: 196170	$13.37B 20.33T KRW 44K%	146.6	South Korea
HLB Co., Ltd. KRX: 028300	$5.51B 8.37T KRW 18K%	-	South Korea
Peptron, Inc. KRX: 087010	$3.99B 6.07T KRW 13K%	-	South Korea
SK bioscience Co.,Ltd. KRX: 302440	$2.25B 3.42T KRW 7K%	-	South Korea

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 598K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 524K%	19.0	United States
argenx SE EBR: ARGX	$47.84B 41.39B EUR 157K%	39.9	Netherlands
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 139K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 139K%	37.2	Switzerland
Natera, Inc. NASDAQ: NTRA	$27.6B 90K%	-	United States

chevron_leftBack